Insider trade report
Open the filing on sec.gov
Cel-Sci Corporation (CVM)
NYSE: CVM · Biological Products, (No Diagnostic Substances) · Vienna, VA · filing with the SEC since 1996
The companyfiscal 2014, as filed
Revenue$264,033+65.5%
Net incomen/a
Earnings per sharen/a
Operating cash flown/a
Cashn/a
Debtn/a
Shareholders’ equityn/a
Shares, dilutedn/a
Return on equity-159.3%
The recordfrom its filings
Filings in 202648
Newest filingOct 1 · 4
Annual reportDec 29, 2025
Quarterly reportAug 14, 2026
Next report due10-K by Dec 29
Insider sales, 12 months$0.00
Insider buys, 12 months$900,000
Patents granted16
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Jun 2026Net income -$22.7MCash from operations -$16.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Employee stock plan registration
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.